- Home
- XERS vs CWH Comparison
XERS vs CWH Comparison
Compare XERS & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | CWH |
|---|---|---|
| Founded | 2005 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | XERS | CWH |
|---|---|---|
| Price | $6.28 | $7.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $10.83 | ★ $15.78 |
| AVG Volume (30 Days) | 1.2M | ★ 3.5M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.41% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | ★ 3.99 |
| Revenue | $49,590,000.00 | ★ $4,792,017,000.00 |
| Revenue This Year | $34.37 | $4.63 |
| Revenue Next Year | $22.86 | $5.72 |
| P/E Ratio | ★ N/A | $1.86 |
| Revenue Growth | ★ 142.67 | 11.83 |
| 52 Week Low | $4.30 | $5.70 |
| 52 Week High | $10.08 | $19.64 |
Technical Indicators
Market Signals| Indicator | XERS | CWH |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 54.14 |
| Support Level | $6.26 | $6.68 |
| Resistance Level | $6.41 | $8.41 |
| Average True Range (ATR) | 0.20 | 0.54 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 71.38 | 59.65 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About CWH Camping World Holdings Inc.
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.